advanced search

INDUSTRIALISATION

DEVELOPMENT & PRODUCTION OF RESPIMAT<sup>®</sup> REUSABLE INHALER HOUSING MODULE
RESPIRATORY
Josef Schmid
Gerresheimer
DEVELOPMENT & PRODUCTION OF RESPIMAT® REUSABLE INHALER HOUSING MODULE
Josef Schmid, Markus Müller and Nina Zielonka discuss Gerresheimer’s recent work on developing the housing module for Boehringer Ingelheim’s new version of the Respimat inhaler.
ONE-STOP SHOP FOR TOTAL MIXING SOLUTIONS FOR PHARMACEUTICAL MANUFACTURERS
INDUSTRIALISATION
Bert Dekens
ONE-STOP SHOP FOR TOTAL MIXING SOLUTIONS FOR PHARMACEUTICAL MANUFACTURERS
Bert Dekens discusses Hosokawa Micron's offering for pharmaceutical powder mixing, including the Cyclomix high-shear mixer and the Nauta low-shear mixer, and how the company’s technology solutions take a broader approach to the full mixing process than simply providing a mixing machine.
COLD FILLING VERSUS PRESSURE FILLING: THE CASE FOR VERSATILE, FULLY INTEGRATED CDMOs
RESPIRATORY
Steve Haswell
Kindeva
COLD FILLING VERSUS PRESSURE FILLING: THE CASE FOR VERSATILE, FULLY INTEGRATED CDMOs
Steve Haswell compares the two main processes for manufacturing pressurised metered dose inhalers – and examines the value for pharmaceutical companies of working with contract development and manufacturing organisations that have expertise in both processes.
PULMO<emp>CRAFT</emp>™: ENGINEERING SPRAY-DRIED POWDERS FOR PULMONARY DELIVERY
PULMONARY
Dr Richard Johnson
Upperton Pharma Solutions
PULMOCRAFT™: ENGINEERING SPRAY-DRIED POWDERS FOR PULMONARY DELIVERY
Richard Johnson discusses the techniques of jet milling and spray drying for the production of formulations for dry powder inhalers, and introduces Upperton Pharma’s PulmoCraft™ technology, which combines the advantages of both.
MG2 AUTOMATION SOLUTIONS FOR INHALATION: R&D, TECHNOLOGICAL PARTNERSHIPS & SUCCESSFUL CASE HISTORIES
PULMONARY
MG2
MG2 AUTOMATION SOLUTIONS FOR INHALATION: R&D, TECHNOLOGICAL PARTNERSHIPS & SUCCESSFUL CASE HISTORIES
Italian automation solutions provider MG2 describes its offering in the inhalation space, including unique benefits of collaboration and two example partnerships.
THE “CUSTOMISABLE PLATFORM” PARADOX
INDUSTRIALISATION
Lyndon Wild
SHL Medical
THE “CUSTOMISABLE PLATFORM” PARADOX
Lyndon Wild and Gene Rhode Fuensalida Pantig present a systematic analysis of the customisable platform architecture found in the Molly® autoinjector technology.
LEVERAGING INTEGRATION THROUGHOUT A DRUG DELIVERY SYSTEM PROJECT
INDUSTRIALISATION
Steven Kaufman
Stevanato Group
LEVERAGING INTEGRATION THROUGHOUT A DRUG DELIVERY SYSTEM PROJECT
Steven Kaufman and Adam Stops describe how an integrated offering can help customers at each phase of a drug delivery system project.
VERIFICATION OF INJECTABLES IN TRANSPORT AND STORAGE
PREFILLED SYRINGES
Mark Turner
Medical Engineering Technologies
VERIFICATION OF INJECTABLES IN TRANSPORT AND STORAGE
Mark Turner discusses the regulations and requirements around testing combination products for their stability in storage over their shelf-life and during transport.
PACKAGING LINE FOR GSK AUTOINJECTORS: A CASE STUDY
INDUSTRIALISATION
Ivan De Sanzo
PACKAGING LINE FOR GSK AUTOINJECTORS: A CASE STUDY
Ivan De Sanzo describes a unique automated complete packaging line provided to GlaxoSmithKline for three different autoinjectors.
INTERVIEW: ERIK HAEFFLER, RECIPHARM
INTERVIEW
Erik Haeffler
Recipharm
INTERVIEW: ERIK HAEFFLER, RECIPHARM
In this interview, Erik Haeffler discusses how the pharma industry can balance optimising environmental sustainability with maintaining the highest safety and efficacy standard for achieving its main objective of promoting patient health and wellbeing.
INNOVATION AND AUTOMATION IN TOPICAL FORMULATION DEVELOPMENT
INDUSTRIALISATION
Prof Marc Brown
MedPharm
INNOVATION AND AUTOMATION IN TOPICAL FORMULATION DEVELOPMENT
Marc Brown, Jon Lenn and Charles Evans discuss the challenges faced by the pharmaceutical industry during the development of topical delivery formulations, and how MedPharm’s performance testing models help identify and mitigate risks during the process.
FROM FORMULATION TO MANUFACTURING: LIPID NANOPARTICLE mRNA VACCINES, GENE THERAPIES & OTHER NANOMEDICINES
INDUSTRIALISATION
Stephen Allan
Evonik
FROM FORMULATION TO MANUFACTURING: LIPID NANOPARTICLE mRNA VACCINES, GENE THERAPIES & OTHER NANOMEDICINES
Stephen Allan reviews the history and formulation advantages of lipid nanoparticles (LNPs) and addresses factors that should be considered by pharmaceutical companies during the CDMO selection process to help reduce regulatory risk, improve product performance and accelerate speed to market.
INTERVIEW WITH AARON MANN, CHIEF EXECUTIVE OFFICER, KINDEVA
INTERVIEW
Aaron Mann
INTERVIEW WITH AARON MANN, CHIEF EXECUTIVE OFFICER, KINDEVA
In this exclusive interview with ONdrugDelivery, Aaron Mann discusses how Kindeva is positioned to move forward as a major CDMO specialising in inhalation and transdermal dosage forms, having been formed from 3M’s drug delivery in May 2020. We also cover the impact of Covid-19, environmental sustainability, and current challenges faced by the pharmaceutical industry.
ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM
ROUNDTABLE
Dr Jeremy Drummond
ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM
In this roundtable discussion, Jeremy Drummond, Stephen Rode and Torkel Gren discuss trends with different drug dosage forms for different routes of administration, the rise of patient centricity including the shift from the blockbuster model to more tailored products.
ADVANCED CAPSULE TECHNOLOGIES: DRY POWDER INHALERS TO TARGET DISEASE
EXPERT VIEW
Frédérique Bordes-Picard
ADVANCED CAPSULE TECHNOLOGIES: DRY POWDER INHALERS TO TARGET DISEASE
Frédérique Bordes-Picard  and Julien Lamps discuss the value of capsule-based dry powder inhalers in the modern respiratory market, the factors driving development in this area and considerations for matching a capsule to a device and formulation.
CUSTOMISING PLATFORM DEVICES: CHALLENGES & CONSIDERATIONS
INDUSTRIALISATION
Doug Boyd
CUSTOMISING PLATFORM DEVICES: CHALLENGES & CONSIDERATIONS
How do you choose the best delivery system for your drug? Doug Boyd explores the pros and cons of a cost-effective, off-the-shelf platform versus a custom drug delivery device, and discusses the challenges and considerations of customising an existing platform device.
MEETING QUALITY DEMANDS THROUGH INTEGRATED PRODUCTS & SERVICES
INDUSTRIALISATION
Lars Keinicke Hansen
Stevanato Group
MEETING QUALITY DEMANDS THROUGH INTEGRATED PRODUCTS & SERVICES
Lars Keinicke Hansen; Chiara Mussoi and Odra Pinato describe how the streamlining of processes and harmonisation of products and services can better serve pharmaceutical companies. A case study highlights how a unique combination of expertise in automation and glass primary packaging benefited pharma giant Merck Serono in a recent project.
INTEGRATING DESIGN AND INDUSTRIALISATION TO OPTIMISE COST, QUALITY & TIME
INDUSTRIALISATION
Pete Evans
SMC Ltd
INTEGRATING DESIGN AND INDUSTRIALISATION TO OPTIMISE COST, QUALITY & TIME
Pete Evans and Meredith Canty explore how integrating design and industrialisation teams can optimise the cost, quality and time of developing a novel drug delivery system.
MEETING DEMAND BY BRINGING MANUFACTURING IN-HOUSE
INDUSTRIALISATION
Bentsi Algazi
Eitan Medical
MEETING DEMAND BY BRINGING MANUFACTURING IN-HOUSE
Bentsi Algazi and Anna Kalika-Rodin discuss the process of developing and implementing in-house production facilities at Sorrel Medical, including cleanroom facilities. The authors discuss the regulatory requirements involved, practical considerations of the design and construction, and the benefits the establishment of in-house facilities confers to Sorrel and its pharmaceutical partners.
APPLICATIONS OF DEEP LEARNING IN MEDICAL DEVICE MANUFACTURING
INDUSTRIALISATION
Frederick Gertz
SHL Medical
APPLICATIONS OF DEEP LEARNING IN MEDICAL DEVICE MANUFACTURING
Frederick Gertz and Gilbert Fluetsch look at how deep learning can be leveraged in a medical device manufacturing environment.
THE FUTURE OF SMART FILL-AND-FINISH
INDUSTRIALISATION
Diana Löber
SCHOTT Pharma
THE FUTURE OF SMART FILL-AND-FINISH
Diana Löber discusses new developments in digitised pharmaceutical manufacturing and the role SCHOTT’s Smart Containers can play in traceability along the entire value chain.
FORMULATION FLEXIBILITY WITH NEW ERA HPMC CAPSULES
GI/ORAL
Sanjay Powale
ACG
FORMULATION FLEXIBILITY WITH NEW ERA HPMC CAPSULES
Sanjay Powale, Anita Solanki and Dorene Almeida discuss the benefits of HPMC capsules in overcoming challenges faced by traditional gelatin capsules.
INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP
INTERVIEW
Steven Kaufman
Stevanato Group
INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP
Steven Kaufman and Uri Baruch discuss the recently announced collaboration between their two companies to accelerate the development of a new variable-dose, cartridge-based pen injector platform for diabetes.
WHICH IS THE BETTER TOXICITY TESTING STRATEGY FOR COMBINATION DEVICES?
EXPERT VIEW
Mark Turner
WHICH IS THE BETTER TOXICITY TESTING STRATEGY FOR COMBINATION DEVICES?
Mark Turner explores the issue of toxicity testing for combination devices and asks which is the better testing strategy – ISO 10993 or extractables and leachables?
Top